Seminar: Non-viral Cell Engineering Advantages and Applications with Stanford University, Touchlight and MaxCyte
About the seminar
This webinar was broadcasted live on November 1, 2023.
In this seminar, cell engineering scientists from Stanford University, Touchlight Genetics, and MaxCyte® shared promising advances in non-viral gene therapy. These experts from across the globe present the latest innovations in gene delivery platforms and single-stranded CRISPR HDR donor technologies.
Key case studies:
- Homology-Independent Targetred Insertion for Clinical-Scale CAR T Manufacturing
Dr. Hyatt Want at Stanford University (Crystal Mackall & Steve Feldman Labs)
- Efficient Gene Knock-ins with megabulbDNA (mbDNA) - a closed synthetic single-stranded CRISPR HDR donor
Dr. Elena Stoyanova at Touchlight Genetics
- Organoid Engineering Case Studies
Dr. Marianna Romito at MaxCyte.
Each presenter shares data on how to increase engineering efficiency in primary and stem cells, all while maintaining high cell viability and recovery for applications in gene editing and autologous/allogeneic cell therapy.